2. tongjitang, the target of reorganization, has naturally become the focus of attention. According to the brief disclosure of the announcement, tongjitang is a Sino-foreign cooperative enterprise with a registered capital of 56.2392 million US dollars, mainly engaged in the wholesale and retail business of drugs, medical devices and other products. According to official website of tongjitang Group, the group is a cluster enterprise integrating chain pharmacies, medical logistics, health management, hospital chain, pension chain, health industrial park and medical health IT. It has more than 60 branches and subsidiaries, with annual sales exceeding 654.38+0.2 billion yuan. It is worth noting that, according to several announcements, during the suspension of hops, tongjitang conducted a new round of unexpected financing, and the list of shareholders of the company was constantly changing. On February 23rd last year, 12, Hepu first disclosed tongjitang's shareholding structure in the announcement of restructuring progress. * * * There are 9 shareholders, of which tongjitang Investment, the major shareholder, holds 59.46% of the shares of the company.
3. tongjitang launched a new round of financing. The shareholding structure of tongjitang announced by the company on February 14 shows that the number of shareholders has increased to 13, among which 4 new faces are Shenzhen Jianjin Holdings 8.3333%, New Century Jinyuan Holdings 5%, New Century Jintong Holdings 5% and Xinjiang Kunjin Holdings 1.6667%. As of March 10, Hepu disclosed that the number of shareholders in tongjitang was 15, and new faces included Shi Sheng Xinjin in Xinjiang, Tian Huan in Tibet Jianxin, Xinjiang Huashi Capital, Shanghai Qingpu and Kaiyuan Jinyuan, and Kaiyuan Jintong withdrew. In the announcement on March 3rd1day, the number of shareholders in tongjitang has been changed to 19, and the Indian-Chinese investor, the former third largest shareholder, withdrew, while PE such as Beijing Jingliangxin Niu Runying and Shanghai Haiyan Crane resumed trading, and once they stepped out of the new century, they rejoined.
:
Tongjitang has at least two financial products tailored for tongjitang's capital increase. According to the publicity materials of "Zhongrong Pearl Gold". "80 Fund Trust Plan", the financing scale of this trust product is 500 million yuan. The Trust Fund invested in Shenzhen Shi Sheng Construction Financial Equity Investment Partnership Company and became a limited partner. The partnership company increased its capital to tongjitang Pharmaceutical Co., Ltd., holding 8.3333%.